Novartis AG
Hedge Funds Holdings
Last updated:
Novartis AG‘s stocks are currently a part of 1096 hedge funds’ portfolios, which represents 9.19% of the total amount of its stocks outstanding. This makes up a total of 207.78M shares of Novartis AG. Compared to the previous quarter, the number fell by -1.45% or -3.05M shares fewer. As for the holding position changes, 36.95% (405) of current hedge fund investors increased the number of shares held, 36.68% (402) of current holders sold a part of the shares held, and 8.21% (90) closed the holdings completely. 83 hedge funds are new holders of Novartis AG stock in Q1 2022, it is 7.57% of total holders.
Hedge funds holding Novartis AG (Q2 2017 – Q1 2022)
| Q2 2017 | 911 |
|---|---|
| Q3 2017 | 928 |
| Q4 2017 | 996 |
| Q1 2018 | 999 |
| Q2 2018 | 976 |
| Q3 2018 | 1,015 |
| Q4 2018 | 1,074 |
| Q1 2019 | 1,118 |
| Q2 2019 | 1,081 |
| Q3 2019 | 1,076 |
| Q4 2019 | 1,152 |
| Q1 2020 | 1,113 |
| Q2 2020 | 1,108 |
| Q3 2020 | 1,099 |
| Q4 2020 | 1,156 |
| Q1 2021 | 1,112 |
| Q2 2021 | 1,100 |
| Q3 2021 | 1,059 |
| Q4 2021 | 1,120 |
| Q1 2022 | 1,096 |
Hedge funds changes in Novartis AG positions (Q2 2017 – Q1 2022)
| Q2 2017 | 88 | 306 | 358 | 58 | 101 |
|---|---|---|---|---|---|
| Q3 2017 | 76 | 342 | 330 | 48 | 132 |
| Q4 2017 | 144 | 338 | 328 | 72 | 114 |
| Q1 2018 | 84 | 368 | 366 | 71 | 110 |
| Q2 2018 | 70 | 341 | 388 | 85 | 92 |
| Q3 2018 | 92 | 360 | 360 | 49 | 154 |
| Q4 2018 | 142 | 340 | 396 | 77 | 119 |
| Q1 2019 | 113 | 416 | 388 | 58 | 143 |
| Q2 2019 | 61 | 426 | 394 | 80 | 120 |
| Q3 2019 | 69 | 352 | 442 | 71 | 142 |
| Q4 2019 | 154 | 405 | 381 | 59 | 153 |
| Q1 2020 | 85 | 418 | 449 | 111 | 50 |
| Q2 2020 | 86 | 397 | 415 | 82 | 128 |
| Q3 2020 | 77 | 342 | 453 | 76 | 151 |
| Q4 2020 | 145 | 377 | 425 | 75 | 134 |
| Q1 2021 | 69 | 412 | 435 | 104 | 92 |
| Q2 2021 | 70 | 396 | 403 | 77 | 154 |
| Q3 2021 | 52 | 368 | 397 | 81 | 161 |
| Q4 2021 | 148 | 326 | 460 | 77 | 109 |
| Q1 2022 | 83 | 405 | 402 | 90 | 116 |
Hedge funds changes in Novartis AG stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 65,061,000 | 42,053,000 |
|---|---|---|
| Q3 2017 | 41,347,000 | 25,275,000 |
| Q4 2017 | 3,057,881,000 | 41,737,000 |
| Q1 2018 | 80,230,000 | 44,150,000 |
| Q2 2018 | 91,838,000 | 25,842,000 |
| Q3 2018 | 82,970,000 | 58,241,000 |
| Q4 2018 | 8,103,649,000 | 5,071,459,000 |
| Q1 2019 | 146,281,000 | 88,116,000 |
| Q2 2019 | 216,132,000 | 103,580,000 |
| Q3 2019 | 142,970,000 | 132,712,000 |
| Q4 2019 | 167,130,000 | 118,860,000 |
| Q1 2020 | 1,137,660,000 | 3,089,403,000 |
| Q2 2020 | 168,470,000 | 13,093,295,000 |
| Q3 2020 | 318,168,066,472 | 2,155,108,465,000 |
| Q4 2020 | 548,216,234,000 | 2,386,101,201,000 |
| Q1 2021 | 252,139,525,000 | 788,066,627,000 |
| Q2 2021 | 127,856,000 | 43,503,000 |
| Q3 2021 | 371,758,000 | 81,773,000 |
| Q4 2021 | 439,529,000 | 121,198,000 |
| Q1 2022 | 197,196,000 | 109,702,000 |